Sunday, September 16, 2007


"Pharmaceutical companies are overstating the effectiveness of their drugs, and may be placing patients at greater risk, because animal laboratory studies they fund are biased, it was claimed yesterday. A survey of nearly 300 animal-test studies involving six different experimental drugs suggested that such flawed methodology is rampant in the drug-testing industry. About two-thirds of the studies, which were all aimed at testing drugs with the potential to treat stroke patients, did not use a proper "randomised blind" methodology, the British Association's Science Festival in York was told." (Independent, 15 September) Why would respectable pharmaceutical firms distort scientific data?
Only to make more money? Surely not. RD

No comments: